A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy

NANot yet recruitingINTERVENTIONAL
Enrollment

5,944

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 31, 2027

Conditions
Liquid Biopsy for Early Screening of Lung Cancer
Interventions
DIAGNOSTIC_TEST

Liquid Biopsy Early Screening

An early screening model for lung cancer aids in identifying individuals with early-stage lung cancer. Those with positive indications of lung cancer will subsequently undergo confirmatory clinical assessments using Low-Dose Computed Tomography (LDCT) in sequence. Ultimately, a definitive diagnosis of lung cancer is established through surgical and pathological examination.

Trial Locations (1)

510120

Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College, Guangzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER

NCT06422637 - A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy | Biotech Hunter | Biotech Hunter